Five Below (FIVE) Q4 2025 earnings review
Record Q4 Shatters Deceleration Fears as Momentum Accelerates
Five Below delivered an exceptional Q4, completely blowing past its own cautious guidance. After warning of a Q4 slowdown to 6-8% comparable sales, the company delivered a massive 15.4% surge, driving revenue up 24.3% YoY to $1.73 billion. Adjusted EPS of $4.31 also crushed expectations. The results validate the strategic turnaround initiated mid-year by CEO Winnie Park, focusing on trend-right product, social media marketing, and an evolved pricing strategy. However, looking ahead, while Q1 2026 guidance remains red-hot (14-16% comps), the full-year outlook of 3-5% implies management expects gravity to take hold with a sharp deceleration in the second half of 2026.
🐂 Bull Case
The turnaround is complete. Comps have accelerated for four straight quarters, from -3.0% in Q4 2024 to +15.4% in Q4 2025, proving the core merchandising and marketing strategies are highly effective.
Despite severe warnings in early 2025 about margin compression from unmitigated tariffs, FY25 adjusted operating margin improved year-over-year, and Q4 margins remained stable at ~18.1%.
🐻 Bear Case
With Q1 2026 guided at 14-16% comps and the full year at 3-5%, mathematical reality dictates a sharp deceleration to flat or negative comps in the back half of the year as the company laps peak performance.
Total inventory jumped 28.3% YoY to $846.6M, outpacing the 24.3% sales growth. If this isn't purely strategic tariff mitigation, it risks future markdowns.
⚖️ Verdict: 🟢
Bullish. The sheer magnitude of the Q4 beat proves the operational execution and product-market fit are elite right now. While H2 2026 presents tough comparisons, the underlying earnings power and unit growth story remain highly compelling.
Key Themes
Comparable Sales Momentum Defies Gravity
Growth is Accelerating. Management guided Q4 comps at a conservative 6-8%, creating a 'deceleration' narrative during the Q3 call. Instead, Q4 delivered a blistering 15.4% comp. This marks the fourth consecutive quarter of accelerating comps, driven by strong traffic and the successful integration of higher price points ($7-$15) into core merchandising.
Implied Second-Half Deceleration for 2026
The guidance sets up a Reversing trend narrative. Q1 2026 is expected to roar at 14-16% comp growth. However, full-year FY26 comp guidance is just 3-5%. This implies that Q2 through Q4 will see dramatic deceleration, potentially dropping into negative territory as the company laps the massive double-digit comps of late FY25.
Inventory Levels Flashing a Modest Warning Sign
While sales grew 24.3% in Q4, total inventory grew 28.3% to $846.6 million (up from $659.5 million a year ago). While previous quarters attributed elevated inventory to a deliberate acceleration of receipts to manage global trade/tariff volatility, it remains a specific data point that contradicts the otherwise flawless operational narrative and requires monitoring for markdown risk.
Successful Fleet Expansion and Store Productivity
The company maintains a Stable, high-growth store rollout, opening 14 net new stores in Q4 to finish FY25 with 150 net new openings (ending at 1,921 stores). Guidance for another 150 stores in FY26 proves real estate availability and new unit economics remain highly supportive of the long-term 3,500 store goal.
Macro: Tariffs Remain a Long-Term Structural Factor
Management noted in the release that FY26 guidance 'includes the expected impact of tariffs in place.' While the company successfully mitigated the 150-200 bps margin hit originally feared in early 2025 (FY25 operating margin actually expanded), the shifting global trade environment means sourcing diversification (e.g., to India) and surgical pricing remain critical defensive mechanisms.
Marketing Pivot and the Connected Customer Journey
The strategic pivot away from traditional channels toward social media and creator-produced content—targeting Gen Alpha, Gen Z, and Millennials—is cementing Five Below as 'THE destination for the Kid.' This strategy, highlighted heavily in Q3, is clearly working, pulling traffic efficiently into the stores.
Other KPIs
Accelerating. Up 32.6% YoY from $356.1 million in FY24. Adjusted operating margin for the full year expanded to 9.9% (up from 9.2% in FY24). This completely erases the early-2025 narrative that tariffs and shrink would heavily compress operating profitability.
Stable and highly liquid. Cash balances more than doubled from $331.7M last year. When combined with $208.5M in short-term investments, the company has nearly $1 billion in total liquidity and zero debt, providing a massive war chest for future store buildouts or potential share repurchases (which are currently excluded from FY26 guidance).
Accelerating. Up 32.3% from $5.04 in FY24, easily beating the previous high-end guidance range. A strong Q4 closeout contributed $4.31 to this total, leveraging fixed expenses beautifully against the 15.4% comp.
Guidance
Accelerating. The midpoint ($1.19B) implies ~22% YoY growth compared to Q1 2025's $970.5M. This shows Q4's incredible momentum is rolling straight into the new fiscal year.
Accelerating. Compounding on top of the 7.1% comp delivered in Q1 2025, this implies a massive two-year stack and represents the company's highest guided growth rate in recent history.
Decelerating growth rate. Midpoint implies 10.2% YoY growth, a significant slowdown from FY25's 22.9% growth, reflecting the challenge of lapping an incredibly strong baseline.
Decelerating. Because Q1 is guided at 14-16%, the full-year 3-5% target implies that Q2, Q3, and Q4 will see drastically lower—possibly flat—comparable sales growth as base effects catch up.
Decelerating. The midpoint of $8.00 implies a ~20% YoY growth rate compared to FY25's 32.3% growth. While slightly slower, it demonstrates structural margin preservation even as the top-line comps normalize.
Key Questions
Bridging the Q1 vs H2 Comps
With Q1 comps guided at an explosive 14-16%, the full-year 3-5% guide implies a severe slowdown in the back half. Is this purely mathematical prudence against tough FY25 comps, or are you seeing macro indicators that suggest a consumer pullback?
Inventory Levels
Inventories ended the year up 28%, outpacing sales growth of 24%. How much of this is a strategic front-loading of receipts to bypass future tariffs versus actual expected volume demand?
Capital Allocation
With nearly $1 billion in total cash and short-term investments and zero debt, and FY26 CapEx capped at ~$250M, how is the board viewing share repurchases given that none are factored into current guidance?